Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Psyence Biomedical Ltd. - Warrants (25/01/2029)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Psyence Biomedical Ltd. - Warrants (25/01/2029) 52 week high is $0.0481 as of September 07, 2025.
What is the 52-week low for Psyence Biomedical Ltd. - Warrants (25/01/2029)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Psyence Biomedical Ltd. - Warrants (25/01/2029) 52 week low is $0.0036 as of September 07, 2025.
What is Psyence Biomedical Ltd. - Warrants (25/01/2029) stock price today?
What is the 50-day moving average of Psyence Biomedical Ltd. - Warrants (25/01/2029)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Psyence Biomedical Ltd. - Warrants (25/01/2029) 50-day moving average is $0.0243.